Delivery Order SPE2DR25D3019-SPE2DR26FK4CW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,648.59 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement, particularly for military and veteran healthcare systems. The place of...
- The Defense Logistics Agency awarded a $41,877.63 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens under a firm fixed price contract type. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction. This delivery order constitutes a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,696.37 firm fixed-price delivery order for Repatha 140 mg/ml SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion scheduled for November 12, 2025. This competitive award, issued on November 10, 2025, carries no set-aside designation and represents a child order under AmerisourceBergen's broader contract vehicle with DLA. This delivery order falls under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $3,406.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of December 3, 2025. This competitively awarded contract, issued with no set-aside designation, represents a single delivery order fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injector pens, with a ceiling value of $4,309.83. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 8, 2025. AmerisourceBergen will fulfill this order from its corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as one of the nation's largest...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a $34,197.25 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular focus on supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $10,575.52 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens under a firm fixed price contract. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $91,225.90 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive award under an existing contract vehicle. The work will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters and a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,839.12 for Repatha 140 mg/ml SureClick auto-injector pens on October 31, 2025, with completion scheduled for November 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DR25D3019Indefinite Delivery Contract
- SPE2DR25D3019-SPE2DR26FK4CWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,258.30 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion targeted for December 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and operates under a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which enables the company to supply pharmaceuticals and medical supplies to support military healthcare programs globally. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's broader IDC vehicle. Repatha is a prescription medication used to treat high cholesterol, and the auto-injector format facilitates self-administration for military and veteran healthcare beneficiaries. The award reflects DLA's ongoing reliance on AmerisourceBergen's extensive pharmaceutical distribution network to fulfill medical supply requirements across the Defense Health Agency and other federal healthcare systems. As a child order under the larger prime contract, this transaction demonstrates the operational efficiency of the IDC model in meeting specific medical product demands within established pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/1/25 |